Multidimensional biomarkers for multiple system atrophy: an update and future directions

被引:4
作者
Wan, Linlin [1 ,3 ,4 ,5 ,8 ]
Zhu, Sudan [1 ]
Chen, Zhao [1 ,3 ,4 ,6 ]
Qiu, Rong [7 ]
Tang, Beisha [1 ,3 ,4 ,6 ]
Jiang, Hong [1 ,2 ,3 ,4 ,6 ,8 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Peoples R China
[2] Cent South Univ, Xiangya Hosp 3, Dept Neurol, Changsha 410013, Peoples R China
[3] Cent South Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Peoples R China
[5] Cent South Univ, Xiangya Hosp, Dept Radiol, Changsha 410008, Peoples R China
[6] Hunan Int Sci & Technol Cooperat Base Neurodegener, Changsha 410008, Peoples R China
[7] Cent South Univ, Sch Comp Sci & Engn, Changsha 410083, Peoples R China
[8] Cent South Univ, Natl Int Collaborat Res Ctr Med Metabol, Changsha 410008, Peoples R China
基金
中国国家自然科学基金;
关键词
Multiple system atrophy; Biomarker; Fluid; Tissue; Gut microbiota; Imaging; ALPHA-SYNUCLEIN LEVELS; NEUROFILAMENT LIGHT-CHAIN; PROGRESSIVE SUPRANUCLEAR PALSY; CEREBROSPINAL-FLUID BIOMARKERS; MYELIN BASIC-PROTEIN; PARKINSONS-DISEASE; DIFFERENTIAL-DIAGNOSIS; OLFACTORY MUCOSA; POTENTIAL BIOMARKER; COENZYME-Q10; LEVELS;
D O I
10.1186/s40035-023-00370-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple system atrophy (MSA) is a fatal progressive neurodegenerative disease. Biomarkers are urgently required for MSA to improve the diagnostic and prognostic accuracy in clinic and facilitate the development and monitoring of disease-modifying therapies. In recent years, significant research efforts have been made in exploring multidimensional biomarkers for MSA. However, currently few biomarkers are available in clinic. In this review, we systematically summarize the latest advances in multidimensional biomarkers for MSA, including biomarkers in fluids, tissues and gut microbiota as well as imaging biomarkers. Future directions for exploration of novel biomarkers and promotion of implementation in clinic are also discussed.
引用
收藏
页数:17
相关论文
共 212 条
  • [1] CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy
    Abdo, W. F.
    de Warrenburg, B. P. C. van
    Kremer, H. P. H.
    Bloem, B. R.
    Verbeek, M. M.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 (08) : 480 - 482
  • [2] CSF α-synuclein does not differentiate between parkinsonian disorders
    Aerts, M. B.
    Esselink, R. A. J.
    Abdo, W. F.
    Bloem, B. R.
    Verbeek, M. M.
    [J]. NEUROBIOLOGY OF AGING, 2012, 33 (02) : 430.e1 - 430.e3
  • [3] Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11C]UCB-J PET Imaging Study
    Andersen, Katrine B.
    Hansen, Allan K.
    Damholdt, Malene F.
    Horsager, Jacob
    Skjaerbaek, Casper
    Gottrup, Hanne
    Klit, Henriette
    Danielsen, Erik H.
    Brooks, David J.
    Borghammer, Per
    [J]. MOVEMENT DISORDERS, 2021, 36 (09) : 2057 - 2065
  • [4] Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study
    Archer, Derek B.
    Bricker, Justin T.
    Chu, Winston T.
    Burciu, Roxana G.
    McCracken, Johanna L.
    Lai, Song
    Coombes, Stephen A.
    Fang, Ruogu
    Barmpoutis, Angelos
    Corcos, Daniel M.
    Kurani, Ajay S.
    Mitchell, Trina
    Black, Mieniecia L.
    Herschel, Ellen
    Simuni, Tanya
    Parrish, Todd B.
    Comella, Cynthia
    Xie, Tao
    Seppi, Klaus
    Bohnen, Nicolaas I.
    Muller, Martijn L. T. M.
    Albin, Roger L.
    Krismer, Florian
    Du, Guangwei
    Lewis, Mechelle M.
    Huang, Xuemei
    Li, Hong
    Pasternak, Ofer
    McFarland, Nikolaus R.
    Okun, Michael S.
    Vaillancourt, David E.
    [J]. LANCET DIGITAL HEALTH, 2019, 1 (05): : E222 - E231
  • [5] MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
    Arshad, Ahmad R.
    Sulaiman, Siti A.
    Saperi, Amalia A.
    Jamal, Rahman
    Ibrahim, Norlinah Mohamed
    Murad, Nor Azian Abdul
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2017, 10
  • [6] Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
    Bacioglu, Mehtap
    Maia, Luis F.
    Preische, Oliver
    Schelle, Juliane
    Apel, Anja
    Kaeser, Stephan A.
    Schweighauser, Manuel
    Eninger, Timo
    Lambert, Marius
    Pilotto, Andrea
    Shimshek, Derya R.
    Neumann, Ulf
    Kahle, Philipp J.
    Staufenbiel, Matthias
    Neumann, Manuela
    Maetzler, Walter
    Kuhle, Jens
    Jucker, Mathias
    [J]. NEURON, 2016, 91 (01) : 56 - 66
  • [7] Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum
    Barca, Emanuele
    Kleiner, Giulio
    Tang, Guomei
    Ziosi, Marcello
    Tadesse, Saba
    Masliah, Eliezer
    Louis, Elan D.
    Faust, Phyllis
    Kang, Un J.
    Torres, Jose
    Cortes, Etty P.
    Vonsattel, Jean-Paul G.
    Kuo, Sheng-Han
    Quinzii, Catarina M.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2016, 75 (07) : 663 - 672
  • [8] Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories
    Bargar, Connor
    De Luca, Chiara Maria Giulia
    Devigili, Grazia
    Elia, Antonio Emanuele
    Cilia, Roberto
    Portaleone, Sara Maria
    Wang, Wen
    Tramacere, Irene
    Bistaffa, Edoardo
    Cazzaniga, Federico Angelo
    Felisati, Giovanni
    Legname, Giuseppe
    Di Fonzo, Alessio
    Xu, Rong
    Gunzler, Steven Alexander
    Giaccone, Giorgio
    Eleopra, Roberto
    Chen, Shu Guang
    Moda, Fabio
    [J]. MOLECULAR NEURODEGENERATION, 2021, 16 (01)
  • [9] Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
    Barichella, Michela
    Severgnini, Marco
    Cilia, Roberto
    Cassani, Erica
    Bolliri, Carlotta
    Caronni, Serena
    Ferri, Valentina
    Cancello, Raffaella
    Ceccarani, Camilla
    Faierman, Samanta
    Pinelli, Giovanna
    De Bellis, Gianluca
    Zecca, Luigi
    Cereda, Emanuele
    Consolandi, Clarissa
    Pezzoli, Gianni
    [J]. MOVEMENT DISORDERS, 2019, 34 (03) : 396 - 405
  • [10] Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
    Beach, Thomas G.
    Adler, Charles H.
    Sue, Lucia I.
    Vedders, Linda
    Lue, LihFen
    White, Charles L., III
    Akiyama, Haru
    Caviness, John N.
    Shill, Holly A.
    Sabbagh, Marwan N.
    Walker, Douglas G.
    [J]. ACTA NEUROPATHOLOGICA, 2010, 119 (06) : 689 - 702